Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Thomas Longerich, Tom Luedde et al.|British Journal of Cancer|2022Cited by 36
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Alwin Krämer, Bianca Kraft et al.|Nature Communications|2023Cited by 36
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across EuropePaul Hofman, Umberto Malapelle, Fiorella Calabrese et al.|ESMO Open|2023Cited by 28
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Felix Sahm, Damian Stichel et al.|Acta Neuropathologica|2021Cited by 23